Vaping has not yet been proven to cause emphysema in the way decades of research have linked conventional cigarettes to the disease, but a growing body of evidence points in a worrying direction. Animal studies show that mice exposed to e-cigarette aerosol develop the hallmark tissue destruction of emphysema, human biomarker studies reveal the same inflammatory and tissue-breakdown signals seen in early-stage emphysema among smokers, and large population surveys associate e-cigarette use with higher rates of the disease. The picture is incomplete because e-cigarettes have only been widely used for about fifteen years, and emphysema typically takes decades to become clinically apparent. Still, the mechanistic evidence is accumulating faster than many users realize.
How Emphysema Develops in the First Place
Emphysema is a form of chronic obstructive pulmonary disease (COPD) in which the tiny air sacs in the lungs, called alveoli, are progressively destroyed. Healthy alveoli are elastic, expanding and contracting with each breath to exchange oxygen and carbon dioxide. In emphysema, the walls between these sacs break down, creating fewer, larger spaces that trap stale air and reduce the total surface area available for gas exchange. The result is increasing breathlessness that worsens over time.
The dominant explanation for why this destruction happens centers on an imbalance between enzymes called proteases, which break down structural proteins in lung tissue, and antiproteases, which normally keep those enzymes in check. When the balance tips toward too much protease activity, the connective tissue scaffold of the lung starts to degrade.1PubMed Central. Role of Proteases in Chronic Obstructive Pulmonary Disease Cigarette smoke triggers this imbalance by flooding the lungs with oxidative stress and recruiting waves of immune cells, particularly neutrophils and macrophages, that release destructive proteases as part of the inflammatory response.2PubMed. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema The central question for vaping is whether e-cigarette aerosol can set off this same cascade.
What Animal Studies Show
Some of the most striking evidence comes from mice. In a widely cited study published in Thorax, researchers exposed mice to e-cigarette aerosol containing nicotine for several months. The animals developed significant airspace enlargement, the structural signature of emphysema, with measurable changes in the three standard indicators lung pathologists use to assess tissue destruction. Mice exposed to the same e-liquid without nicotine did not show these changes, pointing to nicotine as a key driver.3Thorax. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner
A longer-term study confirmed and extended these findings. Adult mice of both sexes exposed to e-cigarette aerosol over an extended period developed pulmonary emphysema characterized by septal destruction and enlarged alveolar spaces, closely resembling the damage seen in mice exposed to conventional cigarette smoke. Female mice appeared more susceptible to the e-cigarette aerosol than males.4PubMed. Long-term e-cigarette aerosol exposure causes pulmonary emphysema in adult female and male mice A separate comparative study found that e-cigarette vapor exposure led to rupture of the alveolar cavity and enlarged alveolar space in male mice, with significant changes in lung function.5Nicotine & Tobacco Research. A Comparative Study of the Effects of Electronic Cigarette and Traditional Cigarette on the Pulmonary Functions of C57BL/6 Male Mice
Mouse lungs are not human lungs, and exposure conditions in a lab do not perfectly replicate how a person vapes. But the consistency of these findings across different research groups and different experimental designs is hard to dismiss. Emphysema-like tissue destruction keeps showing up in animals exposed to e-cigarette aerosol, and it keeps tracking with nicotine content.
The Protease Problem in Vapers’ Lungs
The bridge between animal models and human disease runs through proteases. Remember the protease-antiprotease imbalance that drives emphysema in smokers: when immune cells dump too many tissue-destroying enzymes into the lungs without enough counter-enzymes to neutralize them, the lung’s structural scaffold starts to collapse.6Annals of the American Thoracic Society. Does Protease–Antiprotease Imbalance Explain Chronic Obstructive Pulmonary Disease?
A study of chronic e-cigarette users found that the same destructive enzymes are elevated in their lungs. Neutrophil elastase and matrix metalloproteinase levels, both proteases implicated in emphysema, were increased. When researchers isolated neutrophils and macrophages and exposed them to nicotine in the lab, the cells released more of these proteases in a dose-dependent manner: the more nicotine, the more enzyme released.7PubMed Central. Chronic E-Cigarette Use Increases Neutrophil Elastase and Matrix Metalloprotease Levels in the Lung Separately, lab experiments exposing neutrophils to e-cigarette vapor extract triggered increased release of MMP-9, a metalloproteinase that chews through the collagen and elastin holding alveolar walls together, along with increased neutrophil elastase activity.8PubMed Central. Electronic cigarette exposure triggers neutrophil inflammatory responses
This is the same enzymatic machinery that destroys alveolar walls in traditional smoking-related emphysema. E-cigarette use appears to activate it through the same pathway, just with a different starting trigger.
Oxidative Stress and DNA Damage from Aerosol
Oxidative stress is the other major force behind emphysema. Reactive oxygen species, unstable molecules that damage cells, are a known component of e-cigarette aerosol. Research measuring these reactive species in the vapor from disposable e-cigarettes found that their concentration varied widely depending on the flavor, with some flavored products generating far more than others. Nicotine concentration also played a role, but flavor chemicals were an independent contributor to the oxidative load.9PubMed Central. Comparative Reactive Oxygen Species (ROS) Content among Various Flavored Disposable Vape Bars, including Cool (Iced) Flavored Bars
Higher power settings amplify the problem. When researchers measured hydroxyl radicals, among the most damaging reactive species, they found that increased wattage and larger puff volumes led to significantly higher production. Vegetable glycerin-based liquids generated more of these radicals than propylene glycol-based liquids, and flavored e-liquids produced more than unflavored ones.10PubMed Central. Hydroxyl Radicals in E‑Cigarette Vapor and E‑Vapor Oxidative Potentials under Different Vaping Patterns At the cellular level, e-cigarette aerosol exposure can trigger DNA damage and activate inflammatory signaling pathways in lung tissue.11PubMed Central. Mechanisms of E-Cigarette Vape-Induced Epithelial Cell Damage
Why does this matter for emphysema specifically? Oxidative stress and protease imbalance are not separate processes. Oxidative stress recruits immune cells to the lungs. Those immune cells release proteases. The proteases destroy tissue. The tissue damage creates more inflammation, which recruits more immune cells. It is a self-reinforcing loop, and e-cigarette aerosol appears to be capable of starting it. Studies of primary human alveolar cells exposed to e-cigarette aerosol over several days found that genes related to reactive oxygen species generation and lipid damage were upregulated, while key immune defense genes were suppressed.12PubMed Central. Impact of e-cigarette aerosol on primary human alveolar epithelial type 2 cells
What Human Population Data Tell Us
While cell studies and animal models reveal how damage might occur, population-level surveys tell us whether it appears to be occurring. The epidemiological evidence, though limited by the relative youth of e-cigarettes, consistently points toward an association between vaping and respiratory disease.
A large longitudinal analysis using data from the Population Assessment of Tobacco and Health (PATH) study found that both current and former e-cigarette users had roughly 30% higher odds of developing a new respiratory disease, including COPD, emphysema, chronic bronchitis, or asthma, compared to people who had never vaped, even after adjusting for conventional cigarette use.13PubMed Central. Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis A separate analysis covering 2013 to 2018 broke the association down by disease and found that e-cigarette use was associated with roughly a 54% increased risk of emphysema specifically and a 62% increased risk of COPD.14JAMA Network Open. Association of Electronic Cigarette Use With Incident Respiratory Conditions Among US Adults From 2013 to 2018
Among people who have never smoked conventional cigarettes, the signal persists. A study of never-cigarette smokers found that e-cigarette users had about 44% higher odds of COPD compared to never-e-cigarette users.15PubMed Central. Electronic cigarette use and its association with asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome among never cigarette smokers That finding is important because it begins to untangle vaping from smoking. The most common critique of vaping epidemiology is that many vapers are former or current smokers, making it hard to separate what the e-cigarette is doing from what the cigarettes already did. Studies limited to never-smokers weaken that objection considerably.
These are observational associations, not proof of causation. People who choose to vape may differ from non-vapers in ways the statistical models cannot fully capture. But when observational data align with animal evidence and mechanistic cell studies, the collective weight of evidence becomes harder to explain away.
Dual Use Makes Things Worse
Most adult vapers in the real world are not exclusively vaping. Many smoke conventional cigarettes alongside their e-cigarettes, a pattern called dual use. A meta-analysis that pooled findings across multiple studies found that dual users had more than three times the odds of COPD compared to never-smokers, with a pooled odds ratio of 3.13.16PubMed Central. Association between current e-cigarette use and chronic obstructive pulmonary disease: a meta-analysis focusing on exclusive e-cigarette users A Korean population study found similar stratification: conventional smoking carried the highest COPD risk, followed closely by dual use, and then exclusive e-cigarette use, all significantly elevated above never-smokers.17PubMed Central. Dual Use of Electronic Cigarettes and Cigarettes Elevates Risk of Chronic Obstructive Pulmonary Disease and Mental Health Issues: Insights from a Korean Health Survey
This matters because many smokers adopt e-cigarettes intending to quit, but end up using both products indefinitely. The idea that vaping while still smoking offers lung protection finds no support in the data. If anything, dual users may be exposing their lungs to the harmful components of both products simultaneously.
Why Flavor Choice Is Not Just a Preference
One of the more underappreciated findings in vaping toxicology is that flavoring chemicals are not biologically inert. A systematic review of the pulmonary effects of e-liquid flavors found that compounds like cinnamaldehyde and menthol activate irritant receptors in the lungs, while flavors including strawberry, cinnamon, and tobacco induce oxidative stress, inflammatory cytokine release, and mitochondrial dysfunction in lung cells.18PubMed Central. Pulmonary effects of e-liquid flavors: a systematic review
Experiments with popular pod-style devices found that specific flavor pods, including menthol, mango, and cucumber varieties, triggered substantial mitochondrial production of reactive oxygen species in lung cells. Classic menthol was the most potent inducer of mitochondrial oxidative stress among the flavors tested.19Scientific Reports. E-cigarette flavored pods induce inflammation, epithelial barrier dysfunction, and DNA damage in lung epithelial cells and monocytes Research on lung epithelial cells also found that watermelon- and strawberry-flavored e-cigarette aerosols caused notable depletion of glutathione, a critical antioxidant defense molecule, more so than other flavors.20PubMed Central. Diverse Impact of E-Cigarette Aerosols on Oxidative Stress and Inflammation in Lung Alveolar Epithelial Cells (A549)
An interesting wrinkle: one study comparing e-liquids found that non-tobacco flavors tended to be more oxidatively reactive than tobacco-flavored liquids, and that adding nicotine to a liquid did not always increase the oxidative load. In some cases, the flavoring chemicals themselves were the dominant source of cellular stress, outstripping nicotine’s contribution.21PLOS ONE. Vapors Produced by Electronic Cigarettes and E-Juices with Flavorings Induce Toxicity, Oxidative Stress, and Inflammatory Response in Lung Epithelial Cells and in Mouse Lung This complicates the picture for users who assume that switching to nicotine-free e-liquids eliminates the lung risk. The flavoring chemicals themselves carry their own biological consequences.
E-cigarette aerosol has also been linked to broader mitochondrial dysfunction through the combined effects of reactive oxygen species, toxic aldehydes, metals, and flavoring agents, with certain flavoring and metal combinations intensifying the damage.22PubMed. Mitochondrial dysfunction induced by E-cigarettes
Biomarkers That Track Tissue Destruction in Vapers
Perhaps the most directly relevant evidence for emphysema in human vapers comes from biomarker studies that measure the chemical byproducts of lung tissue breakdown. One study of e-cigarette users’ blood found elevated levels of desmosine, a molecule released when elastin, the structural protein that gives alveoli their stretch, is broken down. Elevated desmosine is a marker of extracellular matrix destruction, the same process that defines emphysema at the tissue level. The same study found increased inflammatory markers including several interleukins, MMP-9, and decreased levels of pro-resolving lipid mediators, molecules the body uses to dial down inflammation. Urine samples showed elevated markers of oxidative stress and oxidative DNA damage.23European Respiratory Journal / ERJ Open Research. Systemic biomarkers in electronic cigarette users: implications for noninvasive assessment of vaping-associated pulmonary injuries
Desmosine elevation is particularly telling. Your body does not produce much desmosine unless elastin is actively being broken down somewhere. The lungs are the largest reservoir of elastin in the body. Finding elevated desmosine in vapers’ blood does not prove emphysema is present, but it shows that the structural protein most critical to alveolar integrity is being degraded at an elevated rate. That is not the profile of a benign exposure.
Metals in Disposable Devices
The hardware itself adds another layer of concern. The heating coils in e-cigarettes are typically made from metal alloys, and as those coils are repeatedly heated and cooled, metals can leach into the aerosol the user inhales.24PubMed Central. Characterization of E-cigarette coil temperature and toxic metal analysis by infrared temperature sensing and scanning electron microscopy – energy-dispersive X-ray Recent testing of popular disposable e-cigarettes found that nickel and lead emissions from several popular brands exceeded health risk thresholds by as much as nine-fold for nickel and four-fold for lead, with the risk assessment noting potential for respiratory disease and lung cancer from chronic inhalation of these metals.25ACS Publications. Elevated Toxic Element Emissions from Popular Disposable E‑Cigarettes: Sources, Life Cycle, and Health Risks
Disposable devices, which have surged in popularity particularly among younger users, may pose a higher risk on this front than refillable devices with replaceable coils, because the entire device is manufactured as cheaply as possible and discarded after use. The aging of the coil within a single device’s life span appears to increase metal emissions over time, meaning the last puffs from a disposable may deliver more metals than the first.
Secondhand Aerosol and Vulnerable Lungs
Secondhand e-cigarette aerosol is often dismissed as harmless water vapor, but it is neither water nor harmless. A systematic review examining the effects of secondhand exposure found that in people who already have COPD, even short-term exposure to secondhand e-cigarette aerosol affected a key lung protein called surfactant protein-A, increased inflammatory markers in the blood, caused throat irritation, and produced borderline declines in lung function.26Journal of Public Health. Effects of secondhand exposure to e-cigarette aerosol on lung health: a systematic review For someone whose lungs are already compromised, passive exposure to vaping aerosol in an enclosed space is not trivial.
Why the Definitive Answer Will Take Time
The honest assessment of this evidence is that vaping activates the same destructive processes in the lung that cause emphysema from smoking, causes emphysema-like tissue damage in animals, and is associated with higher rates of emphysema and COPD in human population studies. What is still missing is a large, long-term prospective study tracking exclusive vapers who never smoked cigarettes from the start of their vaping through decades of follow-up, confirming that clinical emphysema develops at a rate significantly above baseline.
That study is essentially impossible to design as a controlled trial for ethical reasons, and observational cohorts are only now accumulating the years of follow-up needed. Emphysema in smokers typically becomes clinically apparent after two to three decades. E-cigarettes have only been mainstream since the early 2010s. The generation that will provide the clearest answer is the one that started vaping as teenagers and has not yet turned forty.
In the meantime, the mechanistic case has reached a point where waiting for that final epidemiological confirmation means accepting a substantial risk. The lungs of vapers are showing elevated tissue-destroying enzymes, elevated markers of elastin breakdown, elevated oxidative stress, and suppressed anti-inflammatory defenses. Every individual line of evidence has caveats; taken together, the pattern is difficult to reconcile with the idea that vaping is safe for the lungs.